"United we defeat malaria in Asia and the Pacific."
About APLMA
Task Forces
Regional Financing for Malaria
Access to Quality Medicines & Other Technologies
The Champions Group
News & Events
Contact Us
Home
News & Events
1st AQMTF Meeting, 12-13 March 2014, Sydney, Australia
Agenda
Papers
APLMA Background Information
APLMA - Terms of Reference
EAS Malaria Statement
Malaria in Asia Pacific Overview
Taskforce-Quality Medicines
Regulation of ACTs in Asia Pacific
Ensuring Access to Malaria Commodities for High-Risk Populations
Market interventions to improve access to quality medicines and diagnostics
Market landscape antimalaria commodities
Presentations
Overview of Malaria in Asia-Pacific with a Focus on Artemisinin Resistance (Dr. Walter Kazadi)
Malaria in India (Mr. Anshu Prakash)
ERAR Regional Hub Overview, Objectives and Priorities
Latest Evidence on Artemisinin Resistance Calls for Intensified Efforts to Withdraw Oral Artemisinin-based Monotherapies from the Markets (Dr. Klara Tisocki)
Regulation of Anti-Malarial Commodities with a Focus on Artemisinin-Combination Therapy in Asia and Pacific (Dr. Paul Lalvani)
Market landscape for Anti-Malaria Commodities (Dr. Sylvia Meek, Ms. Joaniter Nankabirwa and Ms. Elizabeth Streat)
Ensuring Access to Malaria Commodities for High-Risk Populations (Dr. Kevin Palmer and Dr. Sean Hewitt)
Market Interventions to Improve Access to Quality Medicines and Diagnostics: Generating Evidence for Malaria Medicine Policy in the Asia-Pacific region (Population Services International)
Outcomes Statement
Participants
Go
‹
›
×
×